SCHEMBL19206902

SCHEMBL19206902

C=C(C(=O)O)c1ccc(C(=O)O)o1.C=C(C(=O)O)c1ccc(C=O)o1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
POLB P06746 3/20 0.40
LMNA P02545 1/20 0.40
ALDH1A1 P00352 4/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
LDHA P00338 1/20 0.37
LDHB P07195 1/20 0.37
HAO1 Q9UJM8 1/20 0.37
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.37
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CSF1R P07333 1/20 0.34
RXRA P19793 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17491877 0.93 KDM4E (0.42) KDM4ETDP1POLBLMNAALDH1A1
SCHEMBL17491865 0.86 TDP1 (0.47) KDM4ETDP1POLBALDH1A1HPGD
SCHEMBL86396 0.86 KDM4E (0.52) KDM4ETDP1POLBLMNAALDH1A1
SCHEMBL17495564 0.86 KDM4E (0.52) KDM4ETDP1POLBLMNAALDH1A1
SCHEMBL24980203 0.76 ALDH1A1 (0.45) KDM4ETDP1POLBLMNAALDH1A1
SCHEMBL29952713 0.75 KDM4E (0.59) KDM4ETDP1POLBLMNAALDH1A1
SCHEMBL18911025 0.74 ALDH1A1 (0.44) KDM4ETDP1POLBLMNAALDH1A1
Sumiki'S Acid SCHEMBL28619852 0.74 TDP1 (0.69) KDM4ETDP1POLBALDH1A1L3MBTL1
SCHEMBL19206900 0.73 TDP1 (0.47) KDM4ETDP1POLBLMNAALDH1A1
SCHEMBL19206901 0.73 TDP1 (0.47) KDM4ETDP1POLBLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180093939-A9 NOVEL MONOMERS FROM BIOMASS NDSU RESEARCH FOUNDATION (US) 2018-04-05 US disclosed
US-20170233325-A1 NOVEL MONOMERS FROM BIOMASS NDSU RESEARCH FOUNDATION (US) 2017-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093939-A9 NOVEL MONOMERS FROM BIOMASS DCXR, MANBA, PGLS KDM4E 2020/4885TDP1 2448/4885POLB 2082/4885
US-20170233325-A1 NOVEL MONOMERS FROM BIOMASS DCXR, MANBA, PGLS KDM4E 2020/4885TDP1 2448/4885POLB 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.